|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 601 13th Street NW |
Address2 | Suite 290 North |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400693064-214
|
||||||||
|
6. House ID# 415240020
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Melanie Nathanson |
Date | 12/31/2023 2:21:32 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S.3393 - The Substance Use Disorder Prevention and Promotes Opioid Recovery and Treatment Reauthorization Act - Issues related to improving access to programs and other tools to help individuals and families impacted by substance use.
H.R. 6363 - Further Continuing Appropriations and Other Extenders Act FY 2024 - Support for the continuation of key government health care programs such as Medicaid DSH.
H.R. 5860 - Continuing Appropriations and Other Extenders Act FY 2024 - Support for the continuation of key government health care programs such as Medicaid DSH.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Focus on enhancing the ability to provide needed health care to families in an affordable manner, while increasing access to needed mental health services and supports
H.R. 5378 - Lower Cost, More Transparency Act of 2023 - Issues related to hospital transparency, the importance of the 340b to hospitals caring for low-income, vulnerable patients and the importance of hospital community benefit programs.
H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to continued and expanded coverage.
HHS Rules, Regulations and Guidance regarding coverage and reimbursement for 340b Hospitals.
HHS Rules, Regulations and Guidance regarding the PHE unwinding process
HHS Rules, Regulations and Guidance regarding maternal health, social determinants of health and other issues driving greater access and equity in the health care system.
HHS Rules, Regulations and Guidance regarding Medicaid Reentry programs covering incarcerated individuals returning to society.
Issues related to commitments to health care's commitment environmental health.
Issues related to food security and nutrition as part of health care.
Issues related to Medicaid DSH, 340b and other programs that help support safety net hospitals to best support care for vulnerable populations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
|
|
|
Megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6363 - Further Continuing Appropriations and Other Extenders Act FY 2024 - Support for the continuation of key government health care programs such as Medicaid DSH.
S. 3430 - Better Mental Health Care, Lower Cost Prescription Drugs and Extenders Act of 2023 - Strong support for needed tools to support access to affordable health care and continuation of vital hospital supports, like Medicaid DSH.
H.R. 5378 - Lower Cost, More Transparency Act of 2023 - Issues related to hospital transparency, the importance of the 340b to hospitals caring for low-income, vulnerable patients and the importance of hospital community benefit programs. Support for the expansion of Medicaid DSH, Community Health Centers and other safety net programs reauthorized in the measure.
H.R. 824 - The Telehealth Benefit Expansion for Workers Act of 2023 - Issues related to continued and expanded coverage.
HHS Rules, Regulations and Guidance regarding coverage and reimbursement for 340b Hospitals.
HHS Rules, Regulations and Guidance regarding the PHE unwinding process
HHS Rules, Regulations and Guidance regarding maternal health, social determinants of health and other issues driving greater access and equity in the health care system.
HHS Rules, Regulations and Guidance regarding Medicaid Reentry programs covering incarcerated individuals returning to society.
Issues related to Medicaid DSH, 340b and other programs that help support safety net hospitals to best support care for vulnerable populations.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Melanie |
Nathanson |
|
|
|
Megan |
Hauck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |